Establishing PNB-qPCR for quantifying minimal ctDNA concentrations during tumour resection
Abstract The analysis of blood plasma or serum as a non-invasive alternative to tissue biopsies is a much-pursued goal in cancer research. Various methods and approaches have been presented to determine a patient’s tumour status, chances of survival, and response to therapy from serum or plasma samp...
Guardado en:
Autores principales: | T. Ehlert, S. Tug, A. Brahmer, V. Neef, F. Heid, C. Werner, B. Jansen-Winkeln, W. Kneist, H. Lang, I. Gockel, P. Simon |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/deef6877bf8c477fbd96d8ff951df021 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Universal probe-based intermediate primer-triggered qPCR (UPIP-qPCR) for SNP genotyping
por: Baowei Li, et al.
Publicado: (2021) -
Dynamic recurrence risk and adjuvant chemotherapy benefit prediction by ctDNA in resected NSCLC
por: Bin Qiu, et al.
Publicado: (2021) -
Advantages and Challenges of Using ctDNA NGS to Assess the Presence of Minimal Residual Disease (MRD) in Solid Tumors
por: Lionel Larribère, et al.
Publicado: (2021) -
Laboratory Exercise to Measure Plasmid Copy Number by qPCR
por: Benjamin David, et al.
Publicado: (2021) -
Comparison of three qPCR-based commercial tests for detection of periodontal pathogens
por: Fridus Van der Weijden, et al.
Publicado: (2021)